COMMUNIQUÉS West-GlobeNewswire

Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering

27/04/2018 - 12:00

NEWTOWN, Pa., April 27, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]

Aino Health AB (publ): Aino Health AB signs cooperation agreement with Finla Occupational Health

27/04/2018 - 11:02

Aino Health and Finla Occupational Health have signed a cooperation agreement regarding Aino's HealthManager platform. Cooperation with Finla will further expand Aino's partner network and enable scalability and growth [...]

FIT Biotech Oy: APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH

27/04/2018 - 10:00

FIT Biotech Oy Company release 27.4.2018 at 11:00 AM EET APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH Tommi Holopainen, MSc Economics, EMBA, has been appointed as a new [...]

Decision on launch of conditional, voluntary offer

27/04/2018 - 09:55

Company announcement 27 April 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

GENFIT: First quarter 2018 financial information

27/04/2018 - 08:04

GENFIT: First quarter 2018 financial information (Unaudited financial information under IFRS) Cash and cash equivalents of €255.2 million at March 31, 2018 Revenues for the first three months of 2018 of €37 thousand [...]

GENFIT : Information financière du premier trimestre 2018

27/04/2018 - 08:04

GENFIT : Information financière du premier trimestre 2018 (Données non auditées établies selon les normes IFRS) Trésorerie et équivalents de trésorerie s'élevant à 255,2 millions d'euros au 31 mars 2018 Chiffre d' [...]

Xbrane Biopharma publishes 2017 Annual Report

27/04/2018 - 08:01

Press release 2018-04-27 Xbrane Biopharma AB's annual report for 2017 is now available at the company's website, www.xbrane.com . The annual report is distributed to the shareholders and others that made such request. [...]

Shire plc : Rule 2.9 Announcement

27/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 April 2018 [...]

Saniona publishes the Annual Report for 2017

27/04/2018 - 08:00

PRESS RELEASE April 27, 2018 Saniona, a leading biotech company in the field of ion channels, today announces that the English version of the Annual report for 2017 is now available on the company’s website www.saniona. [...]

Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018

27/04/2018 - 07:34

Company announcement - No. 13/2018 Zealand announces net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® for the first quarter of 2018 Net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® of EUR 14.5 million/USD 17 [...]

Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER

27/04/2018 - 07:32

Paris, April 27, 2018 First-quarter 2018 Business EPS (1) up 1.4% at CER Q1 2018 Change Change at CER IFRS net sales reported €7,898m -8.7% -0.4% IFRS net income reported €1,016m -82.2% (2) - IFRS EPS reported €0.81 -82 [...]

Sanofi : Hausse de 1,4% du BNPA des activités(1) à taux de change constants au premier trimestre 2018

27/04/2018 - 07:32

Paris, le 27 avril 2018 Hausse de 1,4% du BNPA des activités (1) à taux de change constants au premier trimestre 2018 T1 2018 Variation Variation à TCC Chiffre d'affaires net IFRS publié €7 898m -8,7% -0,4% Résultat net [...]

DBV Technologies Reports March 31, 2018 Cash Position

27/04/2018 - 07:31

Montrouge, France, April 27, 2018 DBV Technologies Reports March 31, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as [...]

DBV Technologies publie sa position de trésorerie au 31 mars 2018

27/04/2018 - 07:31

Montrouge, France, le 27 avril (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 31 mars 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]

Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018

27/04/2018 - 07:31

Mechelen, Belgium; 27 April 2018, 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) presents preclinical results showing broad beneficial effects on cartilage and bone with GLPG1972 in an osteoarthritis (OA) rat [...]

ThromboGenics Initiates Phase 2 Clinical Study Evaluating anti-PlGF (THR-317) in combination with anti-VEGF (ranibizumab) for treatment of Diabetic Macular Edema (DME)

27/04/2018 - 07:30

Press release Leuven, Belgium, April 27 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the [...]

Basilea announces appointment of Chief Technology Officer and appointment of Head of Global Quality Management

27/04/2018 - 07:16

Dr. Gerrit Hauck appointed as Chief Technology Officer, succeeding Dr. Günter Ditzinger who will take on new responsibilities at Basilea Dr. Anne Stehlin succeeding Dr. Josef Künzle as Head of Global Quality Management [...]

TiGenix: Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018

27/04/2018 - 07:01

PRESS RELEASE Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018 Leuven (BELGIUM) - April 27, 2018, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG) (" [...]

TiGenix: Publication du prospectus et mémoire en réponse pour l'offre publique d'acquisition de Takeda débutant le 30 avril 2018

27/04/2018 - 07:01

COMMUNIQUÉ DE PRESSE Publication du prospectus et mémoire en réponse pour l'offre publique d'acquisition de Takeda débutant le 30 avril 2018 Louvain (Belgique) - 27 avril 2018, 7:00h CEST - TiGenix NV (Euronext [...]